BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$275.94 USD
+0.34 (0.12%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $275.92 -0.02 (-0.01%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth B Momentum D VGM
Brokerage Reports
0 items in cart
Bio-Rad Laboratories, Inc. [BIO]
Reports for Purchase
Showing records 101 - 120 ( 139 total )
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department